• Reduces levels of total cholesterol, LDL- Cholesterol, toggle cedes and VLDL-Cholesterol, and increases HDL-Cholesterol. • In CHD patients, exhibits more efficacious results than lovastatin, provastatin, Fluvastatin and simvastatin in actively target LDL-cholestrol. • More cost effective than other most HMG-COA reduetare inhibition in achieving target LDL cholesterol levels. • Well tolerated with moderate and transient adverse events.